CO2_2016 - page 29

COMPANY PROFILE
Our team is a dynamic,
dedicated group of individuals
united by a passion for service
and a commitment to quality
and innovation. Our unique
combination of industry
acumen, technical expertise
and entrepreneurial skills make
Alcami a leading provider of
comprehensive outsourcing
services to the pharmaceutical
and biotechnology industries.
Chimica Oggi - Chemistry Today
customer's publication
Connected at every level
AAIPharma Services Corporation and
Cambridge Major Laboratories, Inc. are now Alcami
AAIPharma Services Corporation (AAI)/Cambridge Major Laboratories, Inc. (CML), a leading provider of custom development and
manufacturing services for the pharmaceutical and biotechnology industries, during DCAT Week 16 in New York announced its new
brand and identity as a leading contract development and manufacturing organization (CDMO) with expanded capabilities and
capacity, the organization to now be known as “Alcami”.
Originally joined together in late 2013, AAI and CML combined to offer analytical testing and development services for active
pharmaceutical ingredients (APIs) with oral solid and parenteral dose finished product capacity. Providing an integrated offering
for both drug substance and drug product at every development stage beginning with solid state chemistry and formulation
development, Alcami believes they have created a robust new outsourcing offering.
Alcami has recently announced significant investments in additional capabilities and capacity for oral solid dose manufacturing,
and parenteral fill-finish capabilities and capacity, including additional sterile lines and lyophilization capacity available now.
Additionally, Alcami will be relocating its current St. Louis Analytical Testing Services to a newstate of the art facility at the Cortex
Innovation Center in St. Louis, MO, which provides innovative analytical testing solutions for manufacturers’ new drug entities,
generic drugs, animal health products, medicated consumer health products, chemicals and biopharmaceuticals.
Stephan Kutzer
, Chief Executive Officer stated “With nearly 1000 employees at seven sites in the United States and Europe, these
upgrades across our facilities in Wilmington, Charleston, Durham, Germantown, Edison, St. Louis, and Weert, The Netherlands,
combined with enhancements in our quality, execution and customer focus, support the overall progress of our growth strategy as
a contract services provider with a renewed commitment to meeting customer needs like never before.
With increases in our capabilities and capacities across all our businesses, our ability to serve the market is stronger than ever.”
Alcami represents the combination of the legacy company names in a contemporary coined name reflective of our
transformation to become a world class solution provider to meet the growing pipeline of new products in development within the
pharmaceutical & biotech industry. It is our commitment to ensure we work seamlessly and tirelessly to ensure we aid in the clinical
progression and commercialization of medicines for our customers.
Stephan Kutzer
Chief Executive Officer - Alcami
27
Chimica Oggi - Chemistry Today
- vol. 34(2) March/April 2016
1...,19,20,21,22,23,24,25,26,27,28 30,31,32,33,34,35,36,37,38,39,...68
Powered by FlippingBook